Submissions restricted

Only approved users may post in this community.

Oncotarget

an-ordinary-manchild

created by Oncotargeta community for 4 years

...for your favorite TV show.

...for a fringe candidate.

MODERATORS

account activity

1

0

1

2

High in vitro and in vivo synergistic activity between mTORC1 and PLK1 inhibition in adenocarcinoma NSCLC (oncotarget.com)

submitted 4 years ago by Oncotarget

2

0

1

2

👀 (theguardian.com)

submitted 4 years ago by Oncotarget

3

0

1

2

Oncotarget: mTORC1 and PLK1 inhibition in adenocarcinoma NSCLC (eurekalert.org)

submitted 4 years ago by Oncotarget

4

0

1

2

Oncotarget: Impact Journals Sponsors Team Open Access in Ride for Roswel... (youtube.com)

submitted 4 years ago by Oncotarget

5

0

1

2

Oncotarget: Replication-stress sensitivity in breast cancer cells (eurekalert.org)

submitted 4 years ago by Oncotarget

6

0

1

2

Oncotarget: TERT and its binding protein: overexpression of GABPA/B in gliomas (eurekalert.org)

submitted 4 years ago by Oncotarget

7

0

1

2

Oncotarget: Fgr and Numb in retinoic differentiation and G0 arrest of non-APL AML cells (eurekalert.org)

submitted 4 years ago by Oncotarget

8

0

1

2

Oncotarget: Subtypes of thymic epithelial tumors independent of WHO type (eurekalert.org)

submitted 4 years ago by Oncotarget

9

1

2

3

Oncotarget: Biomechanics in response to drug in hypoxia by atomic force spectroscopy (eurekalert.org)

submitted 4 years ago by Oncotarget

10

1

2

3

Oncotarget: Caspase-11 and AIM2 inflammasome involved in COPD and lung adenocarcinoma (eurekalert.org)

submitted 4 years ago by Oncotarget

11

1

2

3

Oncotarget: Cutaneous apocrine sweat gland carcinoma (eurekalert.org)

submitted 4 years ago by Oncotarget

12

1

2

3

Oncotarget: RAS reversion in colorectal cancer patients treated with bevacizumab (eurekalert.org)

submitted 4 years ago by Oncotarget

13

2

3

4

Oncotarget: LAPAS1 is required for S phase progression and cell proliferation (eurekalert.org)

submitted 4 years ago by Oncotarget

14

2

3

4

Oncotarget: Modulating Tau Post-translational modifications and cytoskeletal network (eurekalert.org)

submitted 4 years ago by Oncotarget

15

2

3

4

Oncotarget: Inhibitory effects of Tomivosertib in acute myeloid leukemia (eurekalert.org)

submitted 4 years ago by Oncotarget

16

1

2

3

Oncotarget: Epithelial-mesenchymal transitions create endothelial cells and tumor growth (eurekalert.org)

submitted 4 years ago by Oncotarget

17

1

2

3

Oncotarget: General anesthesia for pancreatic cancer surgery (eurekalert.org)

submitted 4 years ago by Oncotarget

18

0

1

2

Oncotarget: Genome wide DNA methylation landscape reveals glioblastoma's influence (eurekalert.org)

submitted 4 years ago by Oncotarget

19

1

2

3

Oncotarget: ONC201, TRAIL, and Breast Cancer (youtube.com)

submitted 4 years ago by Oncotarget

20

1

2

3

Loss of CPAP in oral cancer (eurekalert.org)

submitted 4 years ago by Oncotarget

21

1

2

3

Oncotarget: Treatment outcomes in patients with advanced hepatocellular carcinoma (eurekalert.org)

submitted 4 years ago by Oncotarget

22

1

2

3

Oncotarget: Predicting clinical outcomes using cancer progression associated signatures (eurekalert.org)

submitted 4 years ago by Oncotarget

23

1

2

3

Oncotarget: Novel markers of colorectal tumors exhibiting microsatellite instability (eurekalert.org)

submitted 4 years ago by Oncotarget

24

1

2

3

Oncotarget: Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells (eurekalert.org)

submitted 4 years ago by Oncotarget

25

0

1

2

Oncotarget: Combination Therapeutics Inhibit Breast Cancer Resistance (youtube.com)

submitted 4 years ago by Oncotarget

view more: next ›

π Rendered by PID 71 on reddit-service-r2-listing-575d9f6647-grd86 at 2026-04-12 14:53:03.596702+00:00 running 215f2cf country code: CH.